FSMLX | VEXRX | FSMLX / VEXRX | |
Total Expense Ratio | 0.67 | 0.33 | 203% |
Annual Report Gross Expense Ratio | 0.68 | 0.33 | 206% |
Fund Existence | 12 years | 24 years | - |
Gain YTD | -3.614 | -0.805 | 449% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.48B | 19.4B | 13% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | 6.15 | 0.38 | 1,625% |
Returns for 3 years | 44.03 | 19.64 | 224% |
Returns for 5 years | 3.73 | 11.99 | 31% |
Returns for 10 years | 26.50 | 16.29 | 163% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RWK | 121.00 | 4.11 | +3.52% |
Invesco S&P MidCap 400 Revenue ETF | |||
PBE | 65.43 | 1.07 | +1.66% |
Invesco Biotechnology & Genome ETF | |||
SPWO | 24.59 | 0.23 | +0.94% |
SP Funds S&P World ETF | |||
DIA | 444.71 | -0.18 | -0.04% |
SPDR® Dow Jones Industrial Avrg ETF Tr | |||
REW | 7.34 | -0.16 | -2.07% |
ProShares UltraShort Technology |